APO Research
Talk to an analyst

APO RESEARCH · REPORT

Valbenazine API

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Valbenazine API Market Outlook and Growth Opportunities 2026

29 December 2025198 pages

Choose your research edition.

Industry ResearchValbenazine API Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Valbenazine API Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Valbenazine API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Valbenazine API Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Valbenazine API Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Valbenazine API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Valbenazine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Valbenazine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Valbenazine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Valbenazine API market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Valbenazine API market include Zhejiang Hengtengfu Pharmaceutical, Shaanxi Dideu Medichem, Nantong HI-FUTURE Biology, Jiangxi LongLife Bio-pharmaceutical, Jiangsu Vcare PharmaTech, Chengdu Miracle Pharmaceutical, SynZeal Research, MSN Laboratories and Lupin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Valbenazine API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Valbenazine API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Valbenazine API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Valbenazine API market size, projected growth trends, production technologies, key applications, and end-use industries.

Valbenazine API Segment by Company

Zhejiang Hengtengfu Pharmaceutical

Shaanxi Dideu Medichem

Nantong HI-FUTURE Biology

Jiangxi LongLife Bio-pharmaceutical

Jiangsu Vcare PharmaTech

Chengdu Miracle Pharmaceutical

SynZeal Research

MSN Laboratories

Lupin

Acharya Chemical

Valbenazine API Segment by Type

Purity ≥ 98%

Purity ≥ 99%

Valbenazine API Segment by Application

Online Sales

Offline Sales

Valbenazine API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Valbenazine API status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Valbenazine API market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Valbenazine API significant trends, drivers, influence factors in global and regions.

6. To analyze Valbenazine API competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valbenazine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Valbenazine API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valbenazine API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Valbenazine API market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Valbenazine API industry.

Chapter 3: Detailed analysis of Valbenazine API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Valbenazine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Valbenazine API in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Valbenazine API Industry Trends Table 2. Valbenazine API Industry Drivers Table 3. Valbenazine API Industry Opportunities and Challenges Table 4. Valbenazine API Industry Restraints Table 5. Global Valbenazine API Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Valbenazine API Revenue Share by Company (2021-2026) Table 7. Global Valbenazine API Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Valbenazine API Sales Volume Share by Company (2021-2026) Table 9. Global Valbenazine API Average Price (US$/Kg) of Company (2021-2026) Table 10. Global Valbenazine API Company Ranking, (2024-2026) & (USD Million) Table 11. Global Valbenazine API Key Company Manufacturing Base & Headquarters Table 12. Global Valbenazine API Company, Product Type & Application Table 13. Global Valbenazine API Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Valbenazine API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Purity ≥ 98% Table 18. Significant Companies of Purity ≥ 99% Table 19. Global Valbenazine API Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Valbenazine API Sales Volume by Type (2021-2026) & (Tons) Table 21. Global Valbenazine API Sales Volume by Type (2027-2032) & (Tons) Table 22. Global Valbenazine API Sales Volume Share by Type (2021-2026) Table 23. Global Valbenazine API Sales Volume Share by Type (2027-2032) Table 24. Global Valbenazine API Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Valbenazine API Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Valbenazine API Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Valbenazine API Sales Value Share by Type (2021-2026) Table 28. Global Valbenazine API Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Online Sales Table 30. Significant Companies of Offline Sales Table 31. Global Valbenazine API Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 32. Global Valbenazine API Sales Volume by Application (2021-2026) & (Tons) Table 33. Global Valbenazine API Sales Volume by Application (2027-2032) & (Tons) Table 34. Global Valbenazine API Sales Volume Share by Application (2021-2026) Table 35. Global Valbenazine API Sales Volume Share by Application (2027-2032) Table 36. Global Valbenazine API Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Valbenazine API Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Valbenazine API Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Valbenazine API Sales Value Share by Application (2021-2026) Table 40. Global Valbenazine API Sales Value Share by Application (2027-2032) Table 41. Global Valbenazine API Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 42. Global Valbenazine API Sales by Region (2021-2026) & (Tons) Table 43. Global Valbenazine API Sales Market Share by Region (2021-2026) Table 44. Global Valbenazine API Sales by Region (2027-2032) & (Tons) Table 45. Global Valbenazine API Sales Market Share by Region (2027-2032) Table 46. Global Valbenazine API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Valbenazine API Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Valbenazine API Sales Value Share by Region (2021-2026) Table 49. Global Valbenazine API Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Valbenazine API Sales Value Share by Region (2027-2032) Table 51. Global Valbenazine API Market Average Price (US$/Kg) by Region (2021-2026) Table 52. Global Valbenazine API Market Average Price (US$/Kg) by Region (2027-2032) Table 53. Global Valbenazine API Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 54. Global Valbenazine API Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Valbenazine API Sales by Country (2021-2026) & (Tons) Table 56. Global Valbenazine API Sales Market Share by Country (2021-2026) Table 57. Global Valbenazine API Sales by Country (2027-2032) & (Tons) Table 58. Global Valbenazine API Sales Market Share by Country (2027-2032) Table 59. Global Valbenazine API Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Valbenazine API Sales Value Market Share by Country (2021-2026) Table 61. Global Valbenazine API Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Valbenazine API Sales Value Market Share by Country (2027-2032) Table 63. Zhejiang Hengtengfu Pharmaceutical Company Information Table 64. Zhejiang Hengtengfu Pharmaceutical Business Overview Table 65. Zhejiang Hengtengfu Pharmaceutical Valbenazine API Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 66. Zhejiang Hengtengfu Pharmaceutical Valbenazine API Product Portfolio Table 67. Zhejiang Hengtengfu Pharmaceutical Recent Development Table 68. Shaanxi Dideu Medichem Company Information Table 69. Shaanxi Dideu Medichem Business Overview Table 70. Shaanxi Dideu Medichem Valbenazine API Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 71. Shaanxi Dideu Medichem Valbenazine API Product Portfolio Table 72. Shaanxi Dideu Medichem Recent Development Table 73. Nantong HI-FUTURE Biology Company Information Table 74. Nantong HI-FUTURE Biology Business Overview Table 75. Nantong HI-FUTURE Biology Valbenazine API Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 76. Nantong HI-FUTURE Biology Valbenazine API Product Portfolio Table 77. Nantong HI-FUTURE Biology Recent Development Table 78. Jiangxi LongLife Bio-pharmaceutical Company Information Table 79. Jiangxi LongLife Bio-pharmaceutical Business Overview Table 80. Jiangxi LongLife Bio-pharmaceutical Valbenazine API Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 81. Jiangxi LongLife Bio-pharmaceutical Valbenazine API Product Portfolio Table 82. Jiangxi LongLife Bio-pharmaceutical Recent Development Table 83. Jiangsu Vcare PharmaTech Company Information Table 84. Jiangsu Vcare PharmaTech Business Overview Table 85. Jiangsu Vcare PharmaTech Valbenazine API Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 86. Jiangsu Vcare PharmaTech Valbenazine API Product Portfolio Table 87. Jiangsu Vcare PharmaTech Recent Development Table 88. Chengdu Miracle Pharmaceutical Company Information Table 89. Chengdu Miracle Pharmaceutical Business Overview Table 90. Chengdu Miracle Pharmaceutical Valbenazine API Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 91. Chengdu Miracle Pharmaceutical Valbenazine API Product Portfolio Table 92. Chengdu Miracle Pharmaceutical Recent Development Table 93. SynZeal Research Company Information Table 94. SynZeal Research Business Overview Table 95. SynZeal Research Valbenazine API Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 96. SynZeal Research Valbenazine API Product Portfolio Table 97. SynZeal Research Recent Development Table 98. MSN Laboratories Company Information Table 99. MSN Laboratories Business Overview Table 100. MSN Laboratories Valbenazine API Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 101. MSN Laboratories Valbenazine API Product Portfolio Table 102. MSN Laboratories Recent Development Table 103. Lupin Company Information Table 104. Lupin Business Overview Table 105. Lupin Valbenazine API Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 106. Lupin Valbenazine API Product Portfolio Table 107. Lupin Recent Development Table 108. Acharya Chemical Company Information Table 109. Acharya Chemical Business Overview Table 110. Acharya Chemical Valbenazine API Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 111. Acharya Chemical Valbenazine API Product Portfolio Table 112. Acharya Chemical Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Valbenazine API Distributors List Table 116. Valbenazine API Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Valbenazine API Product Image Figure 2. Global Valbenazine API Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Valbenazine API Sales Value (2021-2032) & (US$ Million) Figure 4. Global Valbenazine API Sales (2021-2032) & (Tons) Figure 5. Global Valbenazine API Sales Average Price (US$/Kg) & (2021-2032) Figure 6. Global Valbenazine API Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Purity ≥ 98% Image Figure 10. Purity ≥ 99% Image Figure 11. Global Valbenazine API Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Valbenazine API Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Valbenazine API Sales Volume Share by Type (2021-2032) Figure 14. Global Valbenazine API Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Valbenazine API Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Valbenazine API Sales Value Share by Type (2021-2032) Figure 17. Online Sales Image Figure 18. Offline Sales Image Figure 19. Global Valbenazine API Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 20. Global Valbenazine API Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Valbenazine API Sales Volume Share by Application (2021-2032) Figure 22. Global Valbenazine API Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Valbenazine API Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Valbenazine API Sales Value Share by Application (2021-2032) Figure 25. Global Valbenazine API Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 26. Global Valbenazine API Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Valbenazine API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Valbenazine API Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Valbenazine API Sales Value (2021-2032) & (US$ Million) Figure 30. North America Valbenazine API Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Valbenazine API Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Valbenazine API Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Valbenazine API Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Valbenazine API Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Valbenazine API Sales Value (2021-2032) & (US$ Million) Figure 36. South America Valbenazine API Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Valbenazine API Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Valbenazine API Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Valbenazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Valbenazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Valbenazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Valbenazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Valbenazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Valbenazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Valbenazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Valbenazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Valbenazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Valbenazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Valbenazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Valbenazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Valbenazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Valbenazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Valbenazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Valbenazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Valbenazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Valbenazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Valbenazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Valbenazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Valbenazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Valbenazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Valbenazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Valbenazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Valbenazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Valbenazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Valbenazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Valbenazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Valbenazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Valbenazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Valbenazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Valbenazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Valbenazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Valbenazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Valbenazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Valbenazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Valbenazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Valbenazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Valbenazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Valbenazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Valbenazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Valbenazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Valbenazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Valbenazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Valbenazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Valbenazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Valbenazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Valbenazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Valbenazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Valbenazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Valbenazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Valbenazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Valbenazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Valbenazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Valbenazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Valbenazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Valbenazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Valbenazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Valbenazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Valbenazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Valbenazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Valbenazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Valbenazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Valbenazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Valbenazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Valbenazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Valbenazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Valbenazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Valbenazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Valbenazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Valbenazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Valbenazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Valbenazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Valbenazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Valbenazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Valbenazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Valbenazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Valbenazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Valbenazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Valbenazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Valbenazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Valbenazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Valbenazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Valbenazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Valbenazine API Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Valbenazine API Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Purity ≥ 98%
  • Purity ≥ 99%
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Zhejiang Hengtengfu Pharmaceutical
  • Shaanxi Dideu Medichem
  • Nantong HI-FUTURE Biology
  • Jiangxi LongLife Bio-pharmaceutical
  • Jiangsu Vcare PharmaTech
  • Chengdu Miracle Pharmaceutical
  • SynZeal Research
  • MSN Laboratories
  • Lupin
  • Acharya Chemical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Valbenazine API Sales Value (2021-2032)
  4. 1.2.2 Global Valbenazine API Sales Volume (2021-2032)
  5. 1.2.3 Global Valbenazine API Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Valbenazine API Market Dynamics
  1. 2.1 Valbenazine API Industry Trends
  2. 2.2 Valbenazine API Industry Drivers
  3. 2.3 Valbenazine API Industry Opportunities and Challenges
  4. 2.4 Valbenazine API Industry Restraints
3 Valbenazine API Market by Company
  1. 3.1 Global Valbenazine API Company Revenue Ranking in 2025
  2. 3.2 Global Valbenazine API Revenue by Company (2021-2026)
  3. 3.3 Global Valbenazine API Sales Volume by Company (2021-2026)
  4. 3.4 Global Valbenazine API Average Price by Company (2021-2026)
  5. 3.5 Global Valbenazine API Company Ranking (2024-2026)
  6. 3.6 Global Valbenazine API Company Manufacturing Base and Headquarters
  7. 3.7 Global Valbenazine API Company Product Type and Application
  8. 3.8 Global Valbenazine API Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Valbenazine API Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Valbenazine API Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Valbenazine API Market by Type
  1. 4.1 Valbenazine API Type Introduction
  2. 4.1.1 Purity ≥ 98%
  3. 4.1.2 Purity ≥ 99%
  4. 4.2 Global Valbenazine API Sales Volume by Type
  5. 4.2.1 Global Valbenazine API Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Valbenazine API Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Valbenazine API Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Valbenazine API Sales Value by Type
  9. 4.3.1 Global Valbenazine API Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Valbenazine API Sales Value by Type (2021-2032)
  11. 4.3.3 Global Valbenazine API Sales Value Share by Type (2021-2032)
5 Valbenazine API Market by Application
  1. 5.1 Valbenazine API Application Introduction
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Valbenazine API Sales Volume by Application
  5. 5.2.1 Global Valbenazine API Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Valbenazine API Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Valbenazine API Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Valbenazine API Sales Value by Application
  9. 5.3.1 Global Valbenazine API Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Valbenazine API Sales Value by Application (2021-2032)
  11. 5.3.3 Global Valbenazine API Sales Value Share by Application (2021-2032)
6 Valbenazine API Regional Sales and Value Analysis
  1. 6.1 Global Valbenazine API Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Valbenazine API Sales by Region (2021-2032)
  3. 6.2.1 Global Valbenazine API Sales by Region: 2021-2026
  4. 6.2.2 Global Valbenazine API Sales by Region (2027-2032)
  5. 6.3 Global Valbenazine API Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Valbenazine API Sales Value by Region (2021-2032)
  7. 6.4.1 Global Valbenazine API Sales Value by Region: 2021-2026
  8. 6.4.2 Global Valbenazine API Sales Value by Region (2027-2032)
  9. 6.5 Global Valbenazine API Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Valbenazine API Sales Value (2021-2032)
  12. 6.6.2 North America Valbenazine API Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Valbenazine API Sales Value (2021-2032)
  15. 6.7.2 Europe Valbenazine API Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Valbenazine API Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Valbenazine API Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Valbenazine API Sales Value (2021-2032)
  21. 6.9.2 South America Valbenazine API Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Valbenazine API Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Valbenazine API Sales Value Share by Country, 2025 VS 2032
7 Valbenazine API Country-level Sales and Value Analysis
  1. 7.1 Global Valbenazine API Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Valbenazine API Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Valbenazine API Sales by Country (2021-2032)
  4. 7.3.1 Global Valbenazine API Sales by Country (2021-2026)
  5. 7.3.2 Global Valbenazine API Sales by Country (2027-2032)
  6. 7.4 Global Valbenazine API Sales Value by Country (2021-2032)
  7. 7.4.1 Global Valbenazine API Sales Value by Country (2021-2026)
  8. 7.4.2 Global Valbenazine API Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Valbenazine API Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Valbenazine API Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Valbenazine API Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Valbenazine API Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Valbenazine API Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Valbenazine API Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Valbenazine API Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Valbenazine API Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Valbenazine API Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Valbenazine API Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Valbenazine API Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Valbenazine API Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Valbenazine API Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Valbenazine API Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Valbenazine API Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Valbenazine API Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Valbenazine API Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Valbenazine API Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Valbenazine API Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Valbenazine API Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Valbenazine API Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Valbenazine API Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Valbenazine API Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Valbenazine API Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Valbenazine API Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Valbenazine API Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Valbenazine API Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Valbenazine API Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Valbenazine API Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Valbenazine API Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Valbenazine API Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Valbenazine API Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Valbenazine API Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Valbenazine API Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Valbenazine API Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Valbenazine API Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Valbenazine API Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Valbenazine API Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Valbenazine API Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Valbenazine API Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Valbenazine API Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Valbenazine API Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Valbenazine API Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Valbenazine API Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Valbenazine API Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Valbenazine API Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Valbenazine API Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Valbenazine API Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Valbenazine API Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Valbenazine API Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Valbenazine API Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Valbenazine API Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Valbenazine API Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Valbenazine API Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Valbenazine API Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Valbenazine API Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Valbenazine API Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Valbenazine API Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Valbenazine API Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Valbenazine API Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Valbenazine API Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Valbenazine API Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Valbenazine API Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Valbenazine API Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Valbenazine API Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Valbenazine API Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Valbenazine API Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Valbenazine API Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Valbenazine API Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Valbenazine API Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Valbenazine API Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Valbenazine API Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Valbenazine API Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Valbenazine API Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Valbenazine API Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Valbenazine API Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Valbenazine API Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Valbenazine API Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Valbenazine API Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Valbenazine API Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Valbenazine API Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Valbenazine API Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Valbenazine API Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Valbenazine API Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Hengtengfu Pharmaceutical
  2. 8.1.1 Zhejiang Hengtengfu Pharmaceutical Company Information
  3. 8.1.2 Zhejiang Hengtengfu Pharmaceutical Business Overview
  4. 8.1.3 Zhejiang Hengtengfu Pharmaceutical Valbenazine API Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Hengtengfu Pharmaceutical Valbenazine API Product Portfolio
  6. 8.1.5 Zhejiang Hengtengfu Pharmaceutical Recent Developments
  7. 8.2 Shaanxi Dideu Medichem
  8. 8.2.1 Shaanxi Dideu Medichem Company Information
  9. 8.2.2 Shaanxi Dideu Medichem Business Overview
  10. 8.2.3 Shaanxi Dideu Medichem Valbenazine API Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Shaanxi Dideu Medichem Valbenazine API Product Portfolio
  12. 8.2.5 Shaanxi Dideu Medichem Recent Developments
  13. 8.3 Nantong HI-FUTURE Biology
  14. 8.3.1 Nantong HI-FUTURE Biology Company Information
  15. 8.3.2 Nantong HI-FUTURE Biology Business Overview
  16. 8.3.3 Nantong HI-FUTURE Biology Valbenazine API Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Nantong HI-FUTURE Biology Valbenazine API Product Portfolio
  18. 8.3.5 Nantong HI-FUTURE Biology Recent Developments
  19. 8.4 Jiangxi LongLife Bio-pharmaceutical
  20. 8.4.1 Jiangxi LongLife Bio-pharmaceutical Company Information
  21. 8.4.2 Jiangxi LongLife Bio-pharmaceutical Business Overview
  22. 8.4.3 Jiangxi LongLife Bio-pharmaceutical Valbenazine API Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Jiangxi LongLife Bio-pharmaceutical Valbenazine API Product Portfolio
  24. 8.4.5 Jiangxi LongLife Bio-pharmaceutical Recent Developments
  25. 8.5 Jiangsu Vcare PharmaTech
  26. 8.5.1 Jiangsu Vcare PharmaTech Company Information
  27. 8.5.2 Jiangsu Vcare PharmaTech Business Overview
  28. 8.5.3 Jiangsu Vcare PharmaTech Valbenazine API Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Jiangsu Vcare PharmaTech Valbenazine API Product Portfolio
  30. 8.5.5 Jiangsu Vcare PharmaTech Recent Developments
  31. 8.6 Chengdu Miracle Pharmaceutical
  32. 8.6.1 Chengdu Miracle Pharmaceutical Company Information
  33. 8.6.2 Chengdu Miracle Pharmaceutical Business Overview
  34. 8.6.3 Chengdu Miracle Pharmaceutical Valbenazine API Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Chengdu Miracle Pharmaceutical Valbenazine API Product Portfolio
  36. 8.6.5 Chengdu Miracle Pharmaceutical Recent Developments
  37. 8.7 SynZeal Research
  38. 8.7.1 SynZeal Research Company Information
  39. 8.7.2 SynZeal Research Business Overview
  40. 8.7.3 SynZeal Research Valbenazine API Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 SynZeal Research Valbenazine API Product Portfolio
  42. 8.7.5 SynZeal Research Recent Developments
  43. 8.8 MSN Laboratories
  44. 8.8.1 MSN Laboratories Company Information
  45. 8.8.2 MSN Laboratories Business Overview
  46. 8.8.3 MSN Laboratories Valbenazine API Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 MSN Laboratories Valbenazine API Product Portfolio
  48. 8.8.5 MSN Laboratories Recent Developments
  49. 8.9 Lupin
  50. 8.9.1 Lupin Company Information
  51. 8.9.2 Lupin Business Overview
  52. 8.9.3 Lupin Valbenazine API Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Lupin Valbenazine API Product Portfolio
  54. 8.9.5 Lupin Recent Developments
  55. 8.10 Acharya Chemical
  56. 8.10.1 Acharya Chemical Company Information
  57. 8.10.2 Acharya Chemical Business Overview
  58. 8.10.3 Acharya Chemical Valbenazine API Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Acharya Chemical Valbenazine API Product Portfolio
  60. 8.10.5 Acharya Chemical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Valbenazine API Value Chain Analysis
  2. 9.1.1 Valbenazine API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Valbenazine API Sales Mode & Process
  6. 9.2 Valbenazine API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Valbenazine API Distributors
  9. 9.2.3 Valbenazine API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst